3186 results for «3703»

Filter By

3186 results

Complex PCI in a TAVI patient - LIVE case

20 May 2025 – From EuroPCR 2025

An 84-year-old patient with a history of ischemic stroke in 2017, hypertension, diabetes, dyslipidemia, and a preserved LV function (63 %) presented with a severe symptomatic aortic stenosis. The coronary angiography revealed a severe and calcified stenosis of the distal left main.
Operators implanted an Edwards Sapien...

Complex PCI in a TAVI patient - LIVE case

Insights into emerging prognostic predictors for patients with coronary artery disease

20 May 2025 – From EuroPCR 2025

Gain insights into emerging prognostic predictors for coronary artery disease patients, including endothelial shear stress as a cardiovascular risk marker, impacts of intravascular imaging stratified by disease pattern, correlations between diastolic blood pressure and SYNTAX score, and long-term wall shear stress risk prediction from the FAME...

Insights into emerging prognostic predictors for patients with coronary artery disease

TAVI in bicuspid aortic valve disease - LIVE Case

20 May 2025 – From EuroPCR 2025

A 79-year-old male patient with atrial fibrillation and RBBB on ECG presented with symptomatic severe bicuspid aortic stenosis. LV function was preserved, and coronary artery disease was noted in LAD and first diagonal. A 26 mm Sapien Ultra Resilia valve was implanted via dual femoral access,...

TAVI in bicuspid aortic valve disease - LIVE Case

From crossroads to crossovers: cracking the left main code

20 May 2025 – From EuroPCR 2025

Navigate complex scenarios in left main coronary artery interventions with this session focusing on protected left main and multivessel disease, IVUS-guided PCI, stent optimization, and in-stent restenosis management. Real-world cases from Azerbaijan, Moldova, and Iraq provide collaborative insights and innovative strategies for challenging coronary anatomy.

From crossroads to crossovers: cracking the left main code

Stable CAD and multivessel disease

20 May 2025 – From EuroPCR 2025

This session delves into the management of stable coronary artery disease (CAD) with multivessel involvement. Learn how clinical and procedural factors influence revascularisation strategies, debate the merits of complete revascularisation, and explore decision-making processes between anatomical and functional approaches through illustrative cases and expert analysis.

Stable CAD and multivessel disease

STEMI - What if a culprit lesion is not identifiable?

20 May 2025 – From EuroPCR 2025

Address challenging STEMI cases where culprit lesions are not immediately identifiable. This session emphasizes the utility of intravascular imaging in guiding decision-making and optimizing percutaneous interventions through illustrative cases involving left main stenosis, ambiguous culprit lesions, and etiological dilemmas in coronary occlusion.

STEMI - What if a culprit lesion is not identifiable?

Strategic decision in stent failure

20 May 2025 – From EuroPCR 2025

Explore strategic decision-making in cases of stent failure in this session presenting complex clinical scenarios. Through detailed case analyses, including challenging left main trifurcation lesions and NSTEMI in the presence of chronic total occlusions, discover treatment approaches and key learnings to optimize patient outcomes.

Strategic decision in stent failure

Novel tools and strategies for acute heart failure

20 May 2025 – From EuroPCR 2025

Explore novel mechanical circulatory support tools and strategies for acute heart failure management, including venoarterial ECMO with a customizable counter-pulsatile ventricular assist device, advanced Impella positioning techniques, mitral TEER for cardiogenic shock with mitral regurgitation, and the interplay between vasoactive and mechanical support in ischemic cardiogenic...

Novel tools and strategies for acute heart failure

TEER for challenging anatomy: from myth to reality

21 May 2025 – From EuroPCR 2025

Explore advanced TEER techniques for challenging anatomies. This session covers indications, periprocedural steps, state-of-the-art procedural methods, and management of failed surgical tricuspid annuloplasty, with case discussions highlighting practical learnings for complex mitral and tricuspid interventions.

TEER for challenging anatomy: from myth to reality

Treatment and prognostic stratification of ACS patients with cardiogenic shock

21 May 2025 – From EuroPCR 2025

This session focuses on treatment and prognostic stratification in ACS patients complicated by cardiogenic shock. Topics include mechanical CPR device performance, SCAI shock grade dynamics, hemorrhagic event predictors, ECMO-related strategies, and evaluation of BCIS conveyance algorithms for out-of-hospital cardiac arrest.

Treatment and prognostic stratification of ACS patients with cardiogenic shock

Resilience and continuity of cardiovascular care in times of crises: the RESIL-Card project

20 May 2025 – From EuroPCR 2025

Reflect on cardiovascular care resilience during crises with insights from the RESIL-Card project initiated by the PCR community. This session shares lessons from the pandemic, presents the development of a novel resilience assessment tool, and outlines future timelines to better prepare cardiac care systems for upcoming...

Resilience and continuity of cardiovascular care in times of crises: the RESIL-Card project

How to build a tricuspid programme?

20 May 2025 – From EuroPCR 2025

Learn how to build a successful tricuspid valve programme with a focus on patient screening protocols, heart team roles, and post-procedural management. Gain expert perspectives on organizational requirements, referral optimization, multidisciplinary collaboration, and quality assessment for tricuspid interventions.

How to build a tricuspid programme?

Align for the future with the Myval Octapro transcatheter heart valve series

20 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session offers a practical and evidence-based update on the Myval Octapro THV. Learn step-by-step techniques for valve-in-valve TAVI using the OctaAlign approach, and understand how intermediate sizes and precise deployment contribute to optimised hemodynamics and long-term durability.

Clinical insights are backed by key data...

Align for the future with the Myval Octapro transcatheter heart valve series

Peripheral artery disease: cutting-edge research and evidence

20 May 2025 – From EuroPCR 2025

Review cutting-edge research and evidence in peripheral artery disease, focusing on IVUS-guided endovascular therapy for femoropopliteal disease, evolving endovascular approaches for Leriche syndrome, predictors of adverse events post-transpedal angioplasty, and multicentre outcomes of distal radial access for radial artery recanalization.

Peripheral artery disease: cutting-edge research and evidence

Major Late-Breaking Trials from EuroPCR 2025

21 May 2025 – From EuroPCR 2025

Discover major late-breaking trials from EuroPCR 2025 in this session presenting pivotal study data. Highlights include meta-analyses from the PROTECTED TAVR and BHF PROTECT-TAVI studies, angiography versus physiology-guided PCI during TAVI (FAITAVI trial), and novel antiplatelet strategies following drug-coated stent implantation in acute coronary syndrome, with...

Major Late-Breaking Trials from EuroPCR 2025

Coronary scaffolds: new developments and applications

21 May 2025 – From EuroPCR 2025

Stay informed on advancements in coronary scaffolds with this session reviewing new developments and applications. Topics include comparative performance of magnesium-based bioresorbable stents, long-term clinical outcomes from the BIOMAG-I and FANTOM BRS studies, and real-world experiences with next-generation thin-strut scaffolds.

Coronary scaffolds: new developments and applications

Treatment dilemmas in STEMI patients with multivessel disease

21 May 2025 – From EuroPCR 2025

Address treatment dilemmas in STEMI patients with multivessel disease through this session focused on imaging and physiology-guided revascularisation strategies. Learn optimal approaches for cases with CABG indications, and timing considerations for non-culprit vessel revascularisation during hospital admission or later stages, supported by illustrative clinical cases.

Treatment dilemmas in STEMI patients with multivessel disease

Mitral TEER in challenging scenarios - Part 2

21 May 2025 – From EuroPCR 2025

This session focuses on challenging scenarios encountered during mitral transcatheter edge-to-edge repair (TEER). Learn about management of complications such as haemolysis, device malfunctions, and complex vascular access issues, supported by instructive case presentations including bailout strategies in cardiogenic shock and infective endocarditis.

Mitral TEER in challenging scenarios - Part 2

Stent technologies, last evidence in coronary interventions

21 May 2025 – From EuroPCR 2025

Update your knowledge on the latest stent technologies and clinical evidence in coronary interventions. This session reviews long-term outcomes of resorbable magnesium scaffolds, seven-year data from the COMPARE-ABSORB trial, bioadaptor versus stent comparisons, dual therapy sirolimus-eluting versus biolimus-eluting stents, and randomized trials on direct stenting versus...

Stent technologies, last evidence in coronary interventions

Imaging-based strategies for complication management in STEMI

21 May 2025 – From EuroPCR 2025

Discover imaging-based strategies to manage complications during STEMI interventions. This session discusses diagnostic clues such as spasm, stuck devices, and slow flow, and illustrates complex scenarios including extreme stent challenges and application of CTO techniques to STEMI cases for optimized outcomes.

Imaging-based strategies for complication management in STEMI
Didn’t find what you were looking for?